Ameliorative potential of Adhatoda vasica against anti-tubercular drugs induced hepatic impairments in female Wistar rats in relation to oxidative stress and xeno-metabolism
- 31 December 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 270, 113771
- https://doi.org/10.1016/j.jep.2020.113771
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium FerulatePLOS ONE, 2013
- Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc UpregulationPLOS ONE, 2013
- Citrus Fruit Intake Is Associated with Lower Serum Bilirubin Concentration among Women with the UGT1A1*28 PolymorphismJournal of Nutrition, 2009
- Rifampicin exacerbates isoniazid‐induced toxicity in human but not in rat hepatocytes in tissue‐like culturesBritish Journal of Pharmacology, 2008
- Xenoreceptors CAR and PXR Activation and Consequences on Lipid Metabolism, Glucose Homeostasis, and Inflammatory ResponseMolecular Pharmaceutics, 2007
- Hepatoprotective activity of Adhatoda vasica aqueous leaf extract on d-galactosamine-induced liver damage in ratsFitoterapia, 2005
- Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicineBritish Journal of Clinical Pharmacology, 2000
- Developmental Expression of CYP2E1 in the Human LiverJBIC Journal of Biological Inorganic Chemistry, 1996
- 1H- and 13C-Nmr Assignments for Some Pyrrolo{2,1b}quinazoline Alkaloids of Adhatoda vasicaJournal of Natural Products, 1994
- Antioxidant Determinations by the Use of a Stable Free RadicalNature, 1958